These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 500185)
1. Adherence of Actinomyces viscosus T14V and T14AV to hydroxyapatite surfaces in vitro and human teeth in vivo. Wheeler TT; Clark WB; Birdsell DC Infect Immun; 1979 Sep; 25(3):1066-74. PubMed ID: 500185 [TBL] [Abstract][Full Text] [Related]
2. Influence of physicochemical parameters on adsorption of Actinomyces viscosus to hydroxyapatite surfaces. Wheeler TT; Clark WB; Lane MD; Grow TE Infect Immun; 1983 Mar; 39(3):1095-101. PubMed ID: 6840836 [TBL] [Abstract][Full Text] [Related]
3. Comparative estimates of bacterial affinities and adsorption sites on hydroxyapatite surfaces. Clark WB; Bammann LL; Gibbons RJ Infect Immun; 1978 Mar; 19(3):846-53. PubMed ID: 640732 [TBL] [Abstract][Full Text] [Related]
4. Role of surface fimbriae (fibrils) in the adsorption of Actinomyces species to saliva-treated hydroxyapatite surfaces. Clark WB; Webb EL; Wheeler TT; Fischlschweiger W; Birdsell DC; Mansheim BJ Infect Immun; 1981 Sep; 33(3):908-17. PubMed ID: 6169645 [TBL] [Abstract][Full Text] [Related]
5. Differences in the adsorptive behavior of human strains of Actinomyces viscosus and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces. Qureshi JV; Gibbons RJ Infect Immun; 1981 Jan; 31(1):261-6. PubMed ID: 7216448 [TBL] [Abstract][Full Text] [Related]
6. Fibril-mediated adherence of Actinomyces viscosus to saliva-treated hydroxyapatite. Wheeler TT; Clark WB Infect Immun; 1980 May; 28(2):577-84. PubMed ID: 7399676 [TBL] [Abstract][Full Text] [Related]
7. Identification of the virulence-associated antigen on the surface fibrils of Actinomyces viscosus T14. Cisar JO; Vatter AE; McIntire FC Infect Immun; 1978 Jan; 19(1):312-9. PubMed ID: 624593 [TBL] [Abstract][Full Text] [Related]
8. Influence of growth medium on adsorption of Streptococcus mutans, Actinomyces viscosus, and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces. Peros WJ; Gibbons RJ Infect Immun; 1981 Apr; 32(1):111-7. PubMed ID: 7216480 [TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of adsorption of Actinomyces viscosus T14V to saliva-treated hydroxyapatite by antibody against type 1 fimbriae. Clark WB; Wheeler TT; Cisar JO Infect Immun; 1984 Feb; 43(2):497-501. PubMed ID: 6141143 [TBL] [Abstract][Full Text] [Related]
10. Role of bacterial interactions in the colonization of oral surfaces of Actinomyces viscosus. Kuramitsu HK; Paul A Infect Immun; 1980 Jul; 29(1):83-90. PubMed ID: 6772577 [TBL] [Abstract][Full Text] [Related]
11. Modification of surface composition of Actinomyces viscosus T14V and T14AV. Powell JT; Fischlschweiger W; Birdsell DC Infect Immun; 1978 Dec; 22(3):934-44. PubMed ID: 730385 [TBL] [Abstract][Full Text] [Related]
12. Human salivary acidic proline-rich proteins and statherin promote the attachment of Actinomyces viscosus LY7 to apatitic surfaces. Gibbons RJ; Hay DI Infect Immun; 1988 Feb; 56(2):439-45. PubMed ID: 2892794 [TBL] [Abstract][Full Text] [Related]
13. Use of lytic bacteriophage for Actinomyces viscosus T14V as a probe for cell surface components mediating intergeneric coaggregation. Delisle AL; Donkersloot JA; Kolenbrander PE; Tylenda CA Infect Immun; 1988 Jan; 56(1):54-9. PubMed ID: 3335409 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of adherence of Actinomyces naeslundii (Actinomyces viscosus) T14V-J1 to saliva-treated hydroxyapatite by a monoclonal antibody to type 1 fimbriae. Nesbitt WE; Beem JE; Leung KP; Stroup S; Swift R; McArthur WP; Clark WB Oral Microbiol Immunol; 1996 Feb; 11(1):51-8. PubMed ID: 8604255 [TBL] [Abstract][Full Text] [Related]
15. Langmuir and scatchard parameters do not describe the binding of Actinomyces viscosus to saliva-treated hydroxyapatite. Moncla BJ; Halfpap L; Birdsell DC J Gen Microbiol; 1985 Oct; 131(10):2619-26. PubMed ID: 4067574 [TBL] [Abstract][Full Text] [Related]